HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anja Knippel Selected Research

M3258

10/2021Improved nonclinical safety profile of a novel, highly selective inhibitor of the immunoproteasome subunit LMP7 (M3258).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anja Knippel Research Topics

Disease

2Neoplasms (Cancer)
10/2021 - 11/2020
1Multiple Myeloma
10/2021
1Hematologic Neoplasms (Hematological Malignancy)
10/2021
1Neutropenia
01/2021
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2021
1Body Weight (Weight, Body)
11/2020
1Hyperphosphatemia
11/2020

Drug/Important Bio-Agent (IBA)

2Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2021 - 11/2020
1M3258IBA
10/2021
1Peptide Hydrolases (Proteases)FDA Link
10/2021
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1TOR Serine-Threonine KinasesIBA
01/2021
1Phosphates (Orthophosphate)IBA
11/2020
1AntibodiesIBA
11/2020
1Immunoglobulin G (IgG)IBA
11/2020

Therapy/Procedure

1Therapeutics
01/2021